Crispr Therapeutics shares owned by Brave Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Brave Asset Management
from 13F filings
Historical chart of Brave Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Brave Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Brave Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8M | 27k | 64.81 |
| 2025-06-30 | $1.3M | 28k | 48.64 |
| 2025-03-31 | $303k | 8.9k | 34.03 |
| 2024-12-31 | $396k | 10k | 39.36 |
| 2024-09-30 | $355k | 7.6k | 46.98 |
| 2024-06-30 | $446k | 8.3k | 54.01 |
| 2024-03-31 | $624k | 9.1k | 68.16 |
| 2023-12-31 | $773k | 12k | 62.60 |
| 2023-09-30 | $303k | 6.7k | 45.39 |
| 2023-06-30 | $374k | 6.7k | 56.14 |
| 2023-03-31 | $346k | 7.6k | 45.23 |
| 2022-03-31 | $220k | 3.5k | 62.86 |
| 2021-12-31 | $265k | 3.5k | 75.71 |
| 2021-09-30 | $280k | 2.5k | 112.00 |